| Dr Ellen Dixon, PHARMD | |
|
400 Veterans Ave, Biloxi, MS 39531-2410 | |
| (228) 523-5000 | |
| Not Available |
| Full Name | Dr Ellen Dixon |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 400 Veterans Ave, Biloxi, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053867804 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | E-14418 (Mississippi) | Secondary |
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | E-14418 (Mississippi) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ellen Dixon, PHARMD 400 Veterans Ave, Biloxi, MS 39531-2410 Ph: (228) 523-5000 | Dr Ellen Dixon, PHARMD 400 Veterans Ave, Biloxi, MS 39531-2410 Ph: (228) 523-5000 |
News Archive
Huge amounts of money - up to $50 billion - are spent every year on pharmaceutical products, a market so large that it is extremely vulnerable to corruption. Recent estimates have shown that as much as 25% of medicines which are procured can be lost to fraud, bribery and other corrupt practices.
"The Senate Appropriations Subcommittee on State and Foreign Operations, with oversight that includes funding for the State Department and USAID, has four new members announced this week with diverse approaches and backgrounds in global health issues," the Center for Global Health Policy's "Science Speaks" blog reports.
Hovione has announced that its licensee Daiichi Sankyo has informed that it intends to use Hovione's TwinCaps dry powder inhaler device in the launch of the compound CS-8958, an inhaled long-acting neuraminidase inhibitor active against the influenza virus.
MannKind Corporation today announced that all follow-up visits have been completed for the patients enrolled in Study 171, a Phase 3 clinical study of AFREZZA (insulin human [rDNA origin]) inhalation powder, an investigational, ultra rapid-acting mealtime insulin therapy, administered using MannKind's next-generation inhaler. MannKind expects to release data from this study later this summer.
Policies allowing genes to be patented can make it more difficult for patients to access testing for important disease-causing gene mutations, according to a series of papers in a special online supplement published by Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics.
› Verified 9 days ago
Allison Louise Mulberry, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 Veterans Ave, Biloxi, MS 39531 Phone: 228-523-5000 | |
Brenda M Wise, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 Fisher St # 2b, Biloxi, MS 39534 Phone: 228-377-9240 | |
Dr. Kim Lovan Hatcher, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 Fisher St, Keesler Afb, Biloxi, MS 39534 Phone: 228-376-3878 | |
Dr. Skylar Marie Grass, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 Fisher St, Biloxi, MS 39534 Phone: 228-376-2273 | |
Joshua Favre, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2405 Pass Rd, Biloxi, MS 39531 Phone: 228-388-3458 Fax: 228-388-4091 | |
Rianne Marie Jones, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10252 Woodlands Dr, Biloxi, MS 39532 Phone: 228-860-0267 |